Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 4:31 PM View:  | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 43% 92.39K to 132.39K | |
| 19-Mar-24 4:31 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 116% 34.42K to 74.42K | |
| 19-Mar-24 4:31 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 46% 86.26K to 126.26K | |
| 19-Mar-24 4:31 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 112,500 | -- | -- | 66% 170.09K to 282.59K | |
| 19-Mar-24 4:31 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 32% 123.23K to 163.23K | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 29-Dec-23 | Purchase | 115,774 | $7.24 | $838,204.00 | 2% 6.98M to 7.1M | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 28-Dec-23 | Purchase | 126,116 | $7.08 | $892,901.00 | 2% 6.86M to 6.98M | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 27-Dec-23 | Private Purchase | 79,726 | $7.20 | $574,027.00 | 1% 6.78M to 6.86M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 26-Dec-23 | Purchase | 54,652 | $6.49 | $354,691.00 | < 1% 6.72M to 6.78M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 22-Dec-23 | Purchase | 250,000 | $6.67 | $1,667,500.00 | 4% 6.47M to 6.72M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 21-Dec-23 | Private Purchase | 200,000 | $6.17 | $1,234,000.00 | 3% 6.27M to 6.47M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 19-Dec-23 | Purchase | 277,008 | $5.36 | $1,484,760.00 | 5% 6.0M to 6.27M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 18-Dec-23 | Purchase | 456,923 | $5.41 | $2,471,950.00 | 8% 5.54M to 6.0M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 15-Dec-23 | Private Purchase | 500,000 | $5.97 | $2,985,000.00 | 10% 5.04M to 5.54M | |
| 16-Nov-23 4:34 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 9,632 | $2.97 | $28,607.00 | (22%) 44.05K to 34.42K | |
| 16-Nov-23 4:35 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 3,036 | $2.97 | $9,016.92 | (3%) 89.29K to 86.26K | |
| 16-Nov-23 4:33 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,558 | $2.97 | $34,327.30 | (6%) 181.65K to 170.09K | |
| 16-Nov-23 4:32 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,558 | $2.97 | $34,327.30 | (9%) 134.78K to 123.23K | |
| 16-Nov-23 4:49 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,266 | $2.97 | $33,460.00 | (11%) 103.66K to 92.39K | |
| 16-Nov-23 4:35 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 5,817 | $2.93 | $17,043.80 | (6%) 95.11K to 89.29K | |
| 16-Nov-23 4:33 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 22,141 | $2.93 | $64,873.10 | (11%) 203.79K to 181.65K | |
| 16-Nov-23 4:32 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 22,141 | $2.93 | $64,873.10 | (14%) 156.93K to 134.78K | |
| 16-Nov-23 4:49 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 21,580 | $2.93 | $63,229.40 | (17%) 125.24K to 103.66K | |
| 16-Nov-23 4:34 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 18,452 | $2.93 | $54,064.40 | (30%) 62.5K to 44.05K | |
| 28-Aug-23 4:40 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 62,500 | -- | -- | 100% 0 to 62.5K | |
| 28-Aug-23 4:38 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 25,000 | -- | -- | 36% 70.11K to 95.11K | |
| 28-Aug-23 4:39 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 75,000 | -- | -- | 58% 128.79K to 203.79K | |
| 28-Aug-23 4:39 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 75,000 | -- | -- | 92% 81.92K to 156.93K | |
| 28-Aug-23 4:37 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 62,500 | -- | -- | 100% 62.74K to 125.24K | |
| 25-Jul-23 4:22 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Sale | 38,262 | $4.83 | $184,805.00 | (38%) 101.0K to 62.74K | |
| 24-Jul-23 6:47 PM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Private Purchase | 200,000 | $5.02 | $1,004,000.00 | 1% 15.39M to 15.59M | |
| 25-Jul-23 4:23 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Sale | 28,699 | $4.83 | $138,616.00 | (29%) 98.81K to 70.11K | |
| 25-Jul-23 4:18 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Sale | 50,677 | $4.83 | $244,770.00 | (28%) 179.47K to 128.79K | |
| 25-Jul-23 4:25 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Sale | 33,789 | $4.83 | $163,201.00 | (29%) 115.71K to 81.92K | |
| 25-Jul-23 4:23 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 21-Jul-23 | Grant | 75,000 | -- | -- | 315% 23.81K to 98.81K | |
| 25-Jul-23 4:18 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 21-Jul-23 | Grant | 150,000 | -- | -- | 509% 29.47K to 179.47K | |
| 25-Jul-23 4:25 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 21-Jul-23 | Grant | 100,000 | -- | -- | 636% 15.71K to 115.71K | |
| 25-Jul-23 4:22 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 21-Jul-23 | Grant | 100,000 | -- | -- | 10000% 1.0K to 101.0K | |
| 11-Jul-22 5:24 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 11-Jul-22 | Private Purchase | 7,500 | $3.40 | $25,500.00 | 91% 8.21K to 15.71K | |
| 05-Jul-22 5:32 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 1,428,570 | $2.10 | $3,000,000.00 | 40% 3.61M to 5.04M | |
| 05-Jul-22 4:10 PM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 4,761,900 | $2.10 | $10,000,000.00 | 45% 10.63M to 15.39M | |
| 05-Jul-22 4:11 PM View: | Stalfort Sean Director | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 238,095 | $2.10 | $499,999.00 | 52% 462.11K to 700.21K | |
| 05-Jul-22 4:13 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 5,714 | $2.10 | $11,999.40 | 229% 2.5K to 8.21K | |
| 05-Jul-22 4:12 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 23,809 | $2.10 | $49,998.90 | 100% 0 to 23.81K | |
| 05-Jul-22 4:13 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 23,809 | $2.10 | $49,998.90 | 421% 5.66K to 29.47K | |
| 06-Dec-21 8:20 AM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 03-Dec-21 | Market Purchase | 19,977 | $9.22 | $184,188.00 | < 1% 10.61M to 10.63M | < 1% |
| 06-Dec-21 8:20 AM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 02-Dec-21 | Market Purchase | 30,023 | $9.45 | $283,717.00 | < 1% 10.58M to 10.61M | (2%) |
| 14-Feb-22 10:00 PM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 06-Jul-21 | Gift | 739,830 | -- | -- | (8%) 9.63M to 8.89M | |
| 14-Feb-22 10:00 PM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 06-Jul-21 | Gift | 739,830 | -- | -- | 8% 8.89M to 9.63M | |
| 07-Jun-21 8:42 AM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 04-Jun-21 | Market Purchase | 2,500 | $9.79 | $24,475.00 | 100% 0 to 2.5K | (< 1%) |
